major depressive disorder
Showing NaN - NaN of 113
MDD Trial in Atlanta (Ketamine, Placebo)
Recruiting
- Major Depressive Disorder
- Ketamine
- Placebo
-
Atlanta, GeorgiaEmory University
Dec 20, 2022
MDD Trial in United States (SAGE-217, Placebo)
MDD, Insomnia Trial in United States (SAGE-217, Placebo)
Terminated
- Major Depressive Disorder
- Insomnia
- SAGE-217
- Placebo
-
Little Rock, Arkansas
- +27 more
Oct 13, 2022
MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)
Completed
- Major Depressive Disorder
- +2 more
- AXS-05 (dextromethorphan and bupropion) oral tablets
-
Phoenix, Arizona
- +50 more
Sep 16, 2022
MDD Trial in Australia, United States (10 mg PRAX-114, 20 mg PRAX-114, 40 mg PRAX-114)
Completed
- Major Depressive Disorder
- 10 mg PRAX-114
- +4 more
-
Lafayette, California
- +23 more
Aug 18, 2022
Anhedonia, MDD Trial in Puerto Rico, United States (Placebo, NBI-1065846)
Recruiting
- Anhedonia
- Major Depressive Disorder
- Placebo
- NBI-1065846
-
Birmingham, Alabama
- +11 more
Jun 27, 2022
MDD Trial in United States (SP-624, Placebo)
Active, not recruiting
- Major Depressive Disorder
- SP-624
- Placebo
-
Phoenix, Arizona
- +38 more
May 13, 2022
MDD, Overweight, Inflammation Trial in Atlanta, Boston (Placebo, EPA 1 g/day, EPA 2 g/day)
Completed
- Major Depressive Disorder
- +2 more
- Placebo
- +3 more
-
Atlanta, Georgia
- +1 more
Apr 4, 2022
MDD Trial in United States (Lumateperone, Placebo)
Recruiting
- Major Depressive Disorder
- Lumateperone
- Placebo
-
Little Rock, Arkansas
- +16 more
Apr 7, 2022
MDD Trial in Worldwide (Lumateperone)
Enrolling by invitation
- Major Depressive Disorder
-
Phoenix, Arizona
- +44 more
Apr 7, 2022
MDD Trial in Canada, United States (PNB01 fixed dose combination of pipamperone and citalopram, Citalopram, Pipamperone)
Completed
- Major Depressive Disorder
- PNB01 fixed dose combination of pipamperone and citalopram
- +2 more
-
Glendale, California
- +30 more
Mar 14, 2022
MDD Trial in United States (BTRX-335140, Placebo)
Active, not recruiting
- Major Depressive Disorder
- BTRX-335140
- Placebo
-
Phoenix, Arizona
- +37 more
Mar 11, 2022
MDD Trial in United States (Levomilnacipran ER, Fluoxetine, Placebo)
Completed
- Major Depressive Disorder
- Levomilnacipran ER
- +2 more
-
Little Rock, Arkansas
- +50 more
Mar 1, 2022
Bipolar Depression, MDD Trial in Worldwide (Lumateperone, Placebos)
Recruiting
- Bipolar Depression
- Major Depressive Disorder
- Lumateperone
- Placebos
-
Garden Grove, California
- +41 more
Feb 28, 2022
MDD Trial in Atlanta, New York, Dallas (ALTO-300 PO Tablet)
Recruiting
- Major Depressive Disorder
- ALTO-300 PO Tablet
-
Atlanta, Georgia
- +2 more
Feb 3, 2022
Post Traumatic Stress Disorder, MDD Trial in Atlanta (Mindfulness-Based Cognitive Therapy)
Recruiting
- Post Traumatic Stress Disorder
- Major Depressive Disorder
- Mindfulness-Based Cognitive Therapy
-
Atlanta, GeorgiaGrady Health System
Nov 8, 2021
Depression, MDD Trial in United States (AXS-05, Placebo)
Completed
- Depression
- Major Depressive Disorder
- AXS-05
- Placebo
-
Phoenix, Arizona
- +42 more
Sep 22, 2021
Depressive Disorder, Depression, Depressive Disorder, Major Trial in United States (Synchronized Transcranial Magnetic
Completed
- Depressive Disorder
- +4 more
- Synchronized Transcranial Magnetic Stimulation (sTMS)
- Sham Stimulation
-
La Jolla, California
- +13 more
Aug 9, 2021
MDD Trial in Worldwide (SPD489 (Lisdexamfetamine dimesylate) + Antidepressant)
Terminated
- Major Depressive Disorder
- SPD489 (Lisdexamfetamine dimesylate) + Antidepressant
-
Birmingham, Alabama
- +211 more
Jun 9, 2021
MDD Trial in United States (Antidepressant + SPD489 (lisdexamfetamine dimesylate), Antidepressant + )
Completed
- Major Depressive Disorder
- Antidepressant + SPD489 (lisdexamfetamine dimesylate)
- Antidepressant + placebo
-
Newport Beach, California
- +14 more
Jun 8, 2021